KEGG   DRUG: Irbesartan and trichlormethiazide
Entry
D10480            Mixture   Drug                                   
Name
Irbesartan and trichlormethiazide;
Irtra (TN)
Component
Irbesartan [DR:D00523], Trichlormethiazide [DR:D00658]
Class
Cardiovascular agent
 DG01925  Renin-angiotensin system inhibitor
 DG03231  Antihypertensive
Metabolizing enzyme substrate
 DG01642  CYP2C9 substrate
 DG02924  UGT substrate
Remark
Therapeutic category: 2149
ATC code: C09DA04
Product: D10480<JP>
Efficacy
Antihypertensive
Comment
Irbesartan is metabolized via glucuronide conjugation and CYP2C9.
Metabolism
Enzyme: CYP2C9 [HSA:1559], UGT [KO:K00699]
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 C CARDIOVASCULAR SYSTEM
  C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
   C09D ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
    C09DA Angiotensin II receptor blockers (ARBs) and diuretics
     C09DA04 Irbesartan and diuretics
      D10480  Irbesartan and trichlormethiazide <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  21  Cardiovascular agents
   214  Antihypertensives
    2149  Others
     D10480  Irbesartan and trichlormethiazide
Drug groups [BR:br08330]
 Cardiovascular agent
  DG01925  Renin-angiotensin system inhibitor
   D10480  Irbesartan and trichlormethiazide
  DG03231  Antihypertensive
   D10480  Irbesartan and trichlormethiazide
 Metabolizing enzyme substrate
  DG01642  CYP2C9 substrate
   D10480  Irbesartan and trichlormethiazide
  DG02924  UGT substrate
   D10480  Irbesartan and trichlormethiazide
Drug classes [BR:br08332]
 Cardiovascular agent
  DG03231  Antihypertensive
   D10480  Irbesartan and trichlormethiazide
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D10480
Other DBs
PubChem: 172232573
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system